00002-7190 Lartruvo - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

00002-7190

Brand Name:

Lartruvo

Generic Name:

Olaratumab

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Substances:

Name: Olaratumab

Strength: 10.0

Unit: mg/mL

Packages:

Code: 00002-7190-01

Description: 1 VIAL, SINGLE-USE in 1 CARTON (0002-7190-01) > 19 mL in 1 VIAL, SINGLE-USE

Effective Date: Feb. 14, 2017

Discontinued: Nov. 27, 2020

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

PDGFR

Orphan Drug Designation:

Status:

No Longer Used